Production (Stage)
Allarity Therapeutics, Inc.
ALLR
$1.03
-$0.035-3.29%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.63M | 5.47M | 1.59M | 2.31M | 2.07M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -798.00K | -- | -5.00K | -- |
| Total Operating Expenses | 3.04M | 7.32M | 2.61M | 3.37M | 4.24M |
| Operating Income | -3.04M | -7.32M | -2.61M | -3.37M | -4.24M |
| Income Before Tax | -2.73M | -7.45M | -11.97M | -1.63M | -3.85M |
| Income Tax Expenses | -- | 0.00 | -377.00K | -- | -4.00K |
| Earnings from Continuing Operations | -2.73M | -7.45M | -11.59M | -1.63M | -3.84M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.73M | -7.45M | -11.59M | -1.63M | -3.84M |
| EBIT | -3.04M | -7.32M | -2.61M | -3.37M | -4.24M |
| EBITDA | -3.03M | -7.32M | -2.61M | -3.37M | -4.24M |
| EPS Basic | -0.25 | -1.72 | -7.71 | -3.34 | -- |
| Normalized Basic EPS | -0.15 | -1.08 | -0.90 | -2.04 | -- |
| EPS Diluted | -0.25 | -1.72 | -7.71 | -3.34 | -- |
| Normalized Diluted EPS | -0.15 | -1.08 | -0.90 | -2.04 | -- |
| Average Basic Shares Outstanding | 11.15M | 4.33M | 1.58M | 499.30K | -- |
| Average Diluted Shares Outstanding | 11.15M | 4.33M | 1.58M | 499.30K | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |